BioPharma Drive: Drug Pricing

DECEMBER 19, 2024

The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a limited grace period before taking any enforcement actions.

Compounding Pharmacies 116

Compounding Pharmacies FDA Pharmacy Marketing 116

BioPharma Drive: Drug Pricing

DECEMBER 2, 2024

The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Compounding Pharmacies 122

Compounding Pharmacies Pharmacy Doctors FDA 122

Drugs.com

OCTOBER 15, 2024

15, 2024 -- Pharmacists may continue making compounded versions of the weight-loss medication tirzepatide while the U.S. TUESDAY, Oct. Food and Drug Administration revisits its Oct. 2 decision to remove the medicine from a national drug shortage.

Compounding Pharmacies 85

Compounding Pharmacies Pharmacy FDA Drugs 85

Drugs.com

MARCH 6, 2024

WEDNESDAY, March 6, 2024 -- Barry Cadden, co-founder of a specialty compounding pharmacy behind a deadly meningitis outbreak in 2012, has been handed a prison sentence of 10 to 15 years in Michigan for involuntary manslaughter.On Tuesday, Cadden.

Compounding Pharmacies 98

Compounding Pharmacies Pharmacy 98

Alta Sciences

DECEMBER 14, 2023

A Closer Look At Our On-Site Compounding Pharmacies shajjar Thu, 12/14/2023 - 21:30 HTML Altasciences' dedicated pharmacists bring a wealth of expertise in controlled substances and complex compounding, ensuring maximum precision and safety standards. Electronic security access to the pharmacy and video monitoring. -

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

Alta Sciences

MAY 15, 2023

and Canadian CPUs with compounding pharmacies, that are integrated with our bioanalytical labs and manufacturing and analytical campus. Altasciences has U.S. In fact, one of our bioanalytical laboratories is located within a few minutes' drive of our Montréal CPU, contributing to speedy data acquisition.

Drug Development 52

Drug Development Clinical Trials Compounding Pharmacies Laboratories 52

Agency IQ

MARCH 25, 2024

FDA addressed the expanding practice of drug compounding in 1992 by issuing a compliance policy guide that clarified that pharmacies which compounded products at certain scales, for certain purposes, or without FDA approval were clearly operating “outside the bounds of traditional pharmacy practice.”

FDA 40

FDA Pharmacy Drugs Production 40